Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adrenergic signaling in cardiomyocytes 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
2 Adrenergic signaling in cardiomyocytes 💬
5件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, SCN5A 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
3 Alcoholism 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
4 Alcoholism 💬
2件: DRD1, DRD2 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
5 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
6 Aldosterone synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
7 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
8 Alzheimer disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
9 Amphetamine addiction 💬
2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
10 Amphetamine addiction 💬
6件: CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
11 Amphetamine addiction 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
12 Amphetamine addiction 💬
1件: DRD1 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
13 Amyotrophic lateral sclerosis 💬
2件: GRIA1, GRIA2 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
14 Amyotrophic lateral sclerosis 💬
1件: SIGMAR1 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
15 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
16 Arrhythmogenic right ventricular cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
17 Bile secretion 💬
1件: CA2 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
18 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
19 Calcium signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
20 Calcium signaling pathway 💬
2件: DRD1, DRD5 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
21 Calcium signaling pathway 💬
2件: HTR2A, HTR2C 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
22 cAMP signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
23 cAMP signaling pathway 💬
8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GRIA1, GRIA2, GRIA3, GRIA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
24 cAMP signaling pathway 💬
3件: DRD1, DRD2, DRD5 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
25 cAMP signaling pathway 💬
1件: HTR1D 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
26 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
27 Carbohydrate digestion and absorption 💬
1件: CACNA1D 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
28 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
29 Cardiac muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
30 Cellular senescence 💬
1件: CACNA1D 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
31 Cellular senescence 💬
1件: CACNA1D 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
32 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
33 cGMP-PKG signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
34 Chemical carcinogenesis - receptor activation 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
35 Chemical carcinogenesis - receptor activation 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
36 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
37 Cholinergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
38 Circadian entrainment 💬
2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
39 Circadian entrainment 💬
6件: CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
40 Cocaine addiction 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
41 Cocaine addiction 💬
2件: DRD1, DRD2 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
42 Cocaine addiction 💬
1件: GRIA2 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
43 Collecting duct acid secretion 💬
1件: CA2 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
44 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
45 Cortisol synthesis and secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
46 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
47 Cushing syndrome 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
48 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
49 Dilated cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
50 Dopaminergic synapse 💬
2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
51 Dopaminergic synapse 💬
7件: CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, SCN1A 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
52 Dopaminergic synapse 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
53 Dopaminergic synapse 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
54 GABAergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
55 GABAergic synapse 💬
20件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
56 GABAergic synapse 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D01253 💬 Clobazam 2件: 140, 144 💬
57 Gap junction 💬
2件: DRD1, DRD2 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
58 Gap junction 💬
2件: HTR2A, HTR2C 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
59 Gastric acid secretion 💬
1件: CA2 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
60 Glutamatergic synapse 💬
2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
61 Glutamatergic synapse 💬
11件: CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
62 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
63 GnRH secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
64 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
65 GnRH signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
66 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
67 Growth hormone synthesis, secretion and action 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
68 Huntington disease 💬
4件: GRIA1, GRIA2, GRIA3, GRIA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
69 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
70 Hypertrophic cardiomyopathy 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
71 Inflammatory mediator regulation of TRP channels 💬
2件: HTR2A, HTR2C 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
72 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
73 Insulin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
74 Long-term depression 💬
3件: GRIA1, GRIA2, GRIA3 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
75 Long-term potentiation 💬
1件: CACNA1C 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
76 Long-term potentiation 💬
3件: CACNA1C, GRIA1, GRIA2 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
77 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
78 MAPK signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
79 Metabolic pathways 💬
2件: CA2, CA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
80 Metabolic pathways 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
81 Morphine addiction 💬
1件: DRD1 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
82 Morphine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D01253 💬 Clobazam 2件: 140, 144 💬
83 Morphine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
84 Neuroactive ligand-receptor interaction 💬
2件: CNR1, CNR2 💬 D10915 💬 Cannabidiol 20件:  2 ,  6 ,  8 , 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
85 Neuroactive ligand-receptor interaction 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
86 Neuroactive ligand-receptor interaction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D01253 💬 Clobazam 2件: 140, 144 💬
87 Neuroactive ligand-receptor interaction 💬
25件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
88 Neuroactive ligand-receptor interaction 💬
3件: HTR1D, HTR2A, HTR2C 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
89 Nicotine addiction 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D01253 💬 Clobazam 2件: 140, 144 💬
90 Nicotine addiction 💬
20件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
91 Nitrogen metabolism 💬
2件: CA2, CA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
92 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
93 Oxytocin signaling pathway 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
94 Pancreatic secretion 💬
1件: CA2 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
95 Parkinson disease 💬
2件: DRD1, DRD2 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
96 Pathways of neurodegeneration - multiple diseases 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
97 Pathways of neurodegeneration - multiple diseases 💬
8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GRIA1, GRIA2, GRIA3, GRIA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
98 Pathways of neurodegeneration - multiple diseases 💬
1件: SIGMAR1 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
99 Phenylalanine metabolism 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
100 Primary bile acid biosynthesis 💬
1件: CYP46A1 💬 D11590 💬 Soticlestat 2件: 140, 144 💬
101 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
102 Prion disease 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
103 Proximal tubule bicarbonate reclamation 💬
2件: CA2, CA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
104 Rap1 signaling pathway 💬
1件: CNR1 💬 D10915 💬 Cannabidiol 20件:  2 ,  6 ,  8 , 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
105 Rap1 signaling pathway 💬
1件: DRD2 💬 D00059 💬 Levodopa 6件:  6 , 17, 90, 140, 164, 201 💬
106 Renin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
107 Renin secretion 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
108 Retrograde endocannabinoid signaling 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
109 Retrograde endocannabinoid signaling 💬
24件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
110 Retrograde endocannabinoid signaling 💬
1件: CNR1 💬 D10915 💬 Cannabidiol 20件:  2 ,  6 ,  8 , 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
111 Retrograde endocannabinoid signaling 💬
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 D01253 💬 Clobazam 2件: 140, 144 💬
112 Serotonergic synapse 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
113 Serotonergic synapse 💬
7件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRB1, GABRB2, GABRB3 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
114 Serotonergic synapse 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
115 Serotonergic synapse 💬
3件: GABRB1, GABRB2, GABRB3 💬 D01253 💬 Clobazam 2件: 140, 144 💬
116 Serotonergic synapse 💬
4件: HTR1D, HTR2A, HTR2C, SLC6A4 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
117 Spinocerebellar ataxia 💬
3件: GRIA1, GRIA2, GRIA3 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
118 Synaptic vesicle cycle 💬
1件: SLC6A4 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
119 Taste transduction 💬
1件: CACNA1C 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
120 Taste transduction 💬
10件: CACNA1C, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, SCN2A, SCN3A, SCN9A 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
121 Taste transduction 💬
6件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬 D01253 💬 Clobazam 2件: 140, 144 💬
122 Taste transduction 💬
1件: HTR1D 💬 D07945 💬 Fenfluramine 4件: 140, 144, 145, 149 💬
123 Thermogenesis 💬
1件: CNR1 💬 D10915 💬 Cannabidiol 20件:  2 ,  6 ,  8 , 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
124 Tight junction 💬
1件: CACNA1D 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
125 Tight junction 💬
1件: CACNA1D 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
126 Transcriptional misregulation in cancer 💬
1件: GRIA3 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
127 Tryptophan metabolism 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
128 Type II diabetes mellitus 💬
2件: CACNA1C, CACNA1D 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
129 Type II diabetes mellitus 💬
2件: CACNA1C, CACNA1D 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬
130 Tyrosine metabolism 💬
1件: DDC 💬 D00558 💬 Carbidopa 7件:  6 , 13, 17, 90, 140, 164, 201 💬
131 Vascular smooth muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D00537 💬 Topiramate 6件:  6 , 97, 140, 144, 156, 193 💬
132 Vascular smooth muscle contraction 💬
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D02356 💬 Verapamil 4件: 58, 96, 140, 167 💬